Universe Pharmaceuticals Inc (UPC): Revenue

Annual figures by period end, from SEC filings.

Figures out of scale. In this company's filings, reported revenue for the year ended 2023-09-30 is more than 100 times total assets. That usually means a value was tagged in the wrong unit. Figures are shown as filed; growth rates are not computed, and the company is left out of screens and comparisons.

$17.86B
Year ended 2025-09-30. As filed; likely tagged in the wrong unit
$32.31B2019-09-30: $33.23M2020-09-30: $30.70M2021-09-30: $47.98M2022-09-30: $40.14M2023-09-30: $32.31B2024-09-30: $23.02B2025-09-30: $17.86B$17.86B
2019-09-30 Revenue (USD) 2025-09-30
Period endedRevenueChange YoYSource filing
2025-09-30$17.86Bn/a2026-01-29, From 2024-10-01
2024-09-30$23.02Bn/a2026-01-29, From 2023-10-01
2023-09-30$32.31Bn/a2026-01-29, From 2022-10-01
2022-09-30$40.14Mn/a2025-04-29, From 2021-10-01
2021-09-30$47.98Mn/a2024-01-30, From 2020-10-01
2020-09-30$30.70Mn/a2023-02-10, From 2019-10-01
2019-09-30$33.23Mn/a2022-01-31, From 2018-10-01